Biotech in Phase 2 trials developing treatments for chronic liver disease.
Industry: Health Care
First Day Return: -13.6%
IPO Data | |
---|---|
IPO Date | 07/24/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $66 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2005 |
Employees at IPO | 15 |
Website www.conatuspharma.com |